Company: SLGN
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0001193125-25-083646
Chunk: 30

Company: SILGAN HOLDINGS INC
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 30
---
 the SEC on February 10, 2025 on behalf of itself and certain of its wholly owned subsidiaries, reporting beneficial ownership as of December 31, 2024. JPMorgan Chase & Co. reported that it, along with certain of its subsidiaries, (i) is the beneficial owner of 5,802,244 shares of our Common Stock, (ii) has the sole power to vote or direct the vote for 5,481,134 shares of our Common Stock, (iii) has sole power to dispose or direct the disposition of 5,802,095 shares of our Common Stock and (iv) has shared power to dispose or direct the disposition of 149 shares of our Common Stock. The business address for JPMorgan Chase & Co. is 383 Madison Avenue, New York, New York 10179, as reported in its Schedule 13G. |

18

EQUITY COMPENSATION PLAN INFORMATION In the table below, we provide information about equity securities of the Company authorized for issuance under all of the Company’s equity compensation plans. The information is as of December 31, 2024.

|                                                            |     |                      -a |     | -b                     |     |                          -c |
| Plan Category                                              |     | Number of securities to 
 be issued upon exercise 
 of outstanding options, 
  warrants and rights(1) |     | Weighted average       
 exercise price of      
 outstanding options,   
 warrants and rights(2) |     |        Number of securities 
     remaining available for 
       future issuance under 
         equity compensation 
 plans (excluding securities 
    reflected in column (a)) |
| Equity compensation plans approved by security holders     |     |            1,100,697(3) |     | —                      |     |                2,563,182(4) |
| Equity compensation plans not approved by security holders |     |                       — |     | —                      |     |                           — |
| Total                                                      |     |               1,100,697 |     | —                      |     |                   2,563,182 |

| (1) | This column contains information regarding restricted stock units that represent the right to receive our Common Stock only. We do not have any options, warrants or other rights outstanding. |

| (2) | Our outstanding restricted stock units do not have any exercise price. We do not have any options, warrants or other rights outstanding. |

| (3) | This amount consists of restricted stock